TAFRO Syndrome and COVID-19

Area of Science:

• Immunology
• Infectious Diseases
• Hematology

Background:

• TAFRO syndrome is a systemic inflammatory disorder marked by thrombocytopenia and anasarca, driven by hyperinflammation and cytokine storms.
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19), also induces cytokine storms and diverse immune manifestations.
• Post-COVID-19 and vaccination, TAFRO syndrome onset has been reported, suggesting a potential link between these conditions.

Purpose of the Study:

• To review the literature associating TAFRO syndrome and Castleman disease with COVID-19 and its vaccination.
• To investigate the similarities and differences in pathogenesis between TAFRO syndrome and COVID-19.
• To examine cytokines and genetic factors implicated in TAFRO syndrome and COVID-19 through case report analysis.

Main Methods:

• Literature review of case reports on TAFRO syndrome or Castleman disease in the context of COVID-19 or vaccination.
• Comparative analysis of cytokine profiles and genetic factors.
• Examination of reported TAFRO-like manifestations following COVID-19 infection or vaccination.

Main Results:

• Both TAFRO syndrome and COVID-19 involve excessive cytokine production and immune dysregulation.
• Case reports indicate a potential association between COVID-19/vaccination and the onset of TAFRO syndrome or TAFRO-like symptoms.
• Similarities and differences in the cytokine storm mechanisms between TAFRO syndrome and COVID-19 require further investigation.

Conclusions:

• Understanding TAFRO-like manifestations post-COVID-19 or vaccination may illuminate TAFRO syndrome pathogenesis.
• The shared mechanism of cytokine storms highlights potential therapeutic targets for both conditions.
• Further research is needed to fully elucidate the complex interplay between TAFRO syndrome, Castleman disease, and SARS-CoV-2 infection.